Cargando…
Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723312/ https://www.ncbi.nlm.nih.gov/pubmed/36483062 http://dx.doi.org/10.1016/j.adro.2022.101072 |
_version_ | 1784844143862743040 |
---|---|
author | Jitwatcharakomol, Tanun Setakoranukul, Jiraporn Ithimakin, Suthinee Krittayaphong, Rungroj Thephamongkhol, Kullathorn |
author_facet | Jitwatcharakomol, Tanun Setakoranukul, Jiraporn Ithimakin, Suthinee Krittayaphong, Rungroj Thephamongkhol, Kullathorn |
author_sort | Jitwatcharakomol, Tanun |
collection | PubMed |
description | PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving IMN-RT with those who did not include coverage of the IMN (non–IMN-RT). This study aimed to determine the relationship between IMN-RT and distant metastasis control in patients with lymph node–positive breast cancer. METHODS AND MATERIALS: This was a single-center retrospective cohort study. Patients were divided into 2 groups: IMN-RT and non–IMN-RT. The criterion of the IMN-RT group was that 80% of the prescribed dose covered ≥98% of the Clinical Target Volume of IMN. The primary outcome was 4-year DMFS, and the secondary outcomes were 4-year overall survival, 4-year disease-free survival, and cardiac toxicity. RESULTS: From January 2012 to December 2018, 570 patients were evaluated (IMN-RT, 143 patients; non–IMN-RT, 427 patients). Propensity score matching decreased the number of patients in each group to 139. The median follow-up was 4.3 years. The 4-year DMFS rates were as follows: IMN-RT, 79.1% (95% confidence interval [CI], 70.1%-85.6%), and non–IMN-RT, 82.8% (95% CI, 74.2%-88.7%; P = .43). The groups’ 4-year overall survival and disease-free survival rates did not differ. The 4-year overall survival rates were 84.3% (95% CI, 76.4%-89.8%) for IMN-RT and 88.1% (95% CI, 81.0%-92.7%; P = .39) for non–IMN-RT. The 4-year disease-free survival rates were 77.1% (95% CI, 68.1%-83.8%) for IMN-RT and 82.1% (95% CI, 73.6%-88.1%; P = .29) for non–IMN-RT. There was no significant difference in cardiac toxicity (IMN-RT, 1.4%; non–IMN-RT, 1.4%; P = 1.0). CONCLUSIONS: In the modern radiation technique era with real-world data, we could not find a benefit of internal mammary irradiation. |
format | Online Article Text |
id | pubmed-9723312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97233122022-12-07 Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study Jitwatcharakomol, Tanun Setakoranukul, Jiraporn Ithimakin, Suthinee Krittayaphong, Rungroj Thephamongkhol, Kullathorn Adv Radiat Oncol Scientific Article PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving IMN-RT with those who did not include coverage of the IMN (non–IMN-RT). This study aimed to determine the relationship between IMN-RT and distant metastasis control in patients with lymph node–positive breast cancer. METHODS AND MATERIALS: This was a single-center retrospective cohort study. Patients were divided into 2 groups: IMN-RT and non–IMN-RT. The criterion of the IMN-RT group was that 80% of the prescribed dose covered ≥98% of the Clinical Target Volume of IMN. The primary outcome was 4-year DMFS, and the secondary outcomes were 4-year overall survival, 4-year disease-free survival, and cardiac toxicity. RESULTS: From January 2012 to December 2018, 570 patients were evaluated (IMN-RT, 143 patients; non–IMN-RT, 427 patients). Propensity score matching decreased the number of patients in each group to 139. The median follow-up was 4.3 years. The 4-year DMFS rates were as follows: IMN-RT, 79.1% (95% confidence interval [CI], 70.1%-85.6%), and non–IMN-RT, 82.8% (95% CI, 74.2%-88.7%; P = .43). The groups’ 4-year overall survival and disease-free survival rates did not differ. The 4-year overall survival rates were 84.3% (95% CI, 76.4%-89.8%) for IMN-RT and 88.1% (95% CI, 81.0%-92.7%; P = .39) for non–IMN-RT. The 4-year disease-free survival rates were 77.1% (95% CI, 68.1%-83.8%) for IMN-RT and 82.1% (95% CI, 73.6%-88.1%; P = .29) for non–IMN-RT. There was no significant difference in cardiac toxicity (IMN-RT, 1.4%; non–IMN-RT, 1.4%; P = 1.0). CONCLUSIONS: In the modern radiation technique era with real-world data, we could not find a benefit of internal mammary irradiation. Elsevier 2022-09-15 /pmc/articles/PMC9723312/ /pubmed/36483062 http://dx.doi.org/10.1016/j.adro.2022.101072 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Jitwatcharakomol, Tanun Setakoranukul, Jiraporn Ithimakin, Suthinee Krittayaphong, Rungroj Thephamongkhol, Kullathorn Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title | Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title_full | Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title_fullStr | Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title_full_unstemmed | Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title_short | Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study |
title_sort | outcomes of patients with breast cancer treated with or without internal mammary irradiation: a single-center, retrospective propensity score–matched study |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723312/ https://www.ncbi.nlm.nih.gov/pubmed/36483062 http://dx.doi.org/10.1016/j.adro.2022.101072 |
work_keys_str_mv | AT jitwatcharakomoltanun outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy AT setakoranukuljiraporn outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy AT ithimakinsuthinee outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy AT krittayaphongrungroj outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy AT thephamongkholkullathorn outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy |